Abstract
The evidence base for coronary perforation (CP) occurring during percutaneous coronary intervention in patients presenting with an acute coronary syndrome (ACS-PCI) is limited with the specific role of acute pharmacology in its clinical presentation unclear. Using the BCIS national PCI database,
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have